Event time: 事件时间:
Published: 文章发布:
Key Results
Actual vs Consensus
EPS: $0.89 vs $0.79 estimate, beat+12.7%.Revenue: $11.1B vs $10.9B estimate, beat+2.1%.Profitability and Cash Flow
Period: 2026 Q3 period ended 2026-09-30Revenue: $11.1B; YoY: -3.4%; QoQ: +1.9%Operating income: $106M; Operating margin: 1.0%; YoY: -22.6%; QoQ: -26.9%Net income: $38M; GAAP diluted EPS: $0.73; YoY: -51.9%; QoQ: -36.7%Operating cash flow: -$159M; Capex: $37M; Free cash flow: -$196MCash: $4.5B; Total debt: $4.0B; Net cash: $529MOfficial release: Molina Healthcare Reports Third Quarter 2026 Financial Results
核心结果
实际值与市场预期
EPS:$0.89 vs $0.79 预期,高于预期+12.7%。营收:$11.1B vs $10.9B 预期,高于预期+2.1%。财务指标
期间:2026 Q3(截至 2026-09-30)营收:$11.1B;同比:-3.4%;环比:+1.9%经营利润:$106M;经营利润率:1.0%;同比:-22.6%;环比:-26.9%净利润:$38M;GAAP 稀释 EPS:$0.73;同比:-51.9%;环比:-36.7%经营现金流:-$159M;资本开支:$37M;自由现金流:-$196M现金:$4.5B;总债务:$4.0B;净现金:$529M